Skip to main content
. 2016 Jun 15;5(6):e003270. doi: 10.1161/JAHA.116.003270

Table 3.

Details of Major Adverse Cardiocerebrovascular Events in the Entire Study Group

No Sleep‐Disordered Breathing (n=115) Sleep‐Disordered Breathing (n=126)
Major adverse cardiocerebrovascular events 9 (7.8) 27 (21.4)
Death 3 (2.6) 10 (7.8)
Recurrence of acute coronary syndrome 2 (1.7) 2 (1.6)
Nonfatal stroke 3 (2.6) 4 (3.2)
Admission for congestive heart failure 1 (0.9) 11 (8.7)

Data are presented as number of patients (percentage).